Press Releases from Cognision (1 total)
Cognision Partners with Anavex for Phase 2 Study of ANAVEX®3-71 Compound
FOR IMMEDIATE RELEASE
Anavex (AVXL) Partners with Cognision for Study of ANAVEX®3-71 in Subjects with Schizophrenia
4/22/2024 - Cognision, providers of advanced neurobiomarker technology, announces its partnership…
Go To Page:
